Brave Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $658K | Buy |
|
|||||
|
2025
Q1 | $184K | Sell |
|
|||||
|
2024
Q4 | $298K | Hold |
|
|||||
|
2024
Q3 | $355K | Hold |
|
|||||
|
2024
Q2 | $408K | Sell |
|
|||||
|
2024
Q1 | $576K | Buy |
|
|||||
|
2023
Q4 | $442K | Buy |
|
|||||
|
2023
Q3 | $212K | Buy |
|
|||||
|
2023
Q2 | $262K | Sell |
|
|||||
|
2023
Q1 | $255K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $220K | Hold |
|
|||||
|
2021
Q4 | $265K | Buy |
|
|||||
|
2021
Q3 | $280K | Buy |
|